Navigation Links
Prebiotics Supplemented Formula Milk Reduces Dermatitis Risk

The risk of developing eczema in babies is reduced by adding prebiotics to their formula milk They help to stimulate the beneficial gut bacteria //and fortifies the immune system.

According to BBC reports, a study done by Milan’s Center for Infant Nutrition revealed that topic dermatitis was less likely to develop in babies given supplemented formula milk than in those given the standard form. The results, published in Archives of Disease in Childhood, suggests that atopic dermatitis may be prevented by the supplements by boosting the immune system.

According to leading scientist, Professor Guido Moro, atopic dermatitis decreased by over 50% in the infants fed with pre-biotics. "To our knowledge this is the first time it has been shown that prebiotics not only produces favorable changes in the gut flora, but could also lead to a genuine clinical benefit".

He adds, "It appears that prebiotics can strengthen the immune system and so reduce the risk of atopic dermatitis during the first months of life."

The research subjected 192 healthy children to the study who had a high risk of developing allergies.


'"/>




Page: 1

Related medicine news :

1. Prebiotics can cut Development of Skin Allergy in Babies at High Risk
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. The Happiness Formula....
4. Indian Government Keen On JE Vaccine Supply And Patenting Of Indian Medicine Formulations
5. UN Formulates Action Plan for Relief to Recovery in Quake-hit Areas of Pakistan
6. Infant’s Formula for good health- Breast-feed, beneficial than formula-fee
7. Formula milk suffering due to commercial interests
8. Efficacy Of Sports-Formulated Jelly Beans In Warding Off Fatigue To Be Studied
9. Winning Formula For Mother and baby - Breast Feeding!
10. Infant Formula With High Iron Content Packs Brain Disorder
11. West African Ministers Formulate Plan To Combat Bird Flu
Post Your Comments:
(Date:12/2/2008)...ON, Dec. 2 In an open l...sociation of Homes and Services for the Aging (AAH...our ways that the Obama administration can make bo...s to the way America cares for its most vulnerable... Expand the Nation,s Work Force: Create Jobs in ...
(Date:12/2/2008)... Dec. 2 Today a group ...ions, elected officials and other community leader...ds in Detroit/Wayne County to solidify participant...ure and economic successes and challenges play a r...t of the opening session of a three-day discussion...
(Date:12/2/2008)...y be better spent in other areas, experts say , ...ital rapid response teams, created to prevent card...do not seem to work, a new study finds. , "Many...ast decade," said lead researcher Dr. Paul S. Chan...e in Kansas City, Mo. "Earlier studies had shown t...
(Date:12/2/2008)...ound most were as effective, despite editorials ur...lthDay News) -- Brand-name drugs used to treat car... new review of available evidence shows. , Yet ...n by specialists, have urged against substituting ...nterparts. , "We found no evidence that brand-n...
Breaking Medicine News(10 mins):Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 2Health News:Think Tank Investigates the Environmental Conditions Surrounding Health Inequities 3Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 3Health News:Generic Heart Drugs as Good as Brand-Name Counterparts 2Health News:Generic Heart Drugs as Good as Brand-Name Counterparts 3
...f dust mites in the bedroom can be achieved by rep...ilation, according to a new study.// In “Distribu...in Europe: The European Community Respiratory Heal...icipal Institute of Medical Research, Barcelona, S...
...t death syndrome has been the cause of many infant...baby sleeps on its back. In a bid to investigate t...able, researchers discovered that infants born wit...nes were prone to the risk of SIDS. The study ha...
... a $20 billion pharma firm based in the Netherland...India and hoped to capture a 10 percent share of t...uously exploring opportunities to invest in India.... million per annum," said company president Gerard...
... by Cancer Research UK finds that many women with ...en seem to genuinely forget to take their medicati...ugs. Difficulty in coping with side effects and i...iven as main reasons for quitting the pills. Anoth...
Other Medicine News:Health News:Replacing Old Mattress, Adding Ventilation Reduces Mites 2
(Date:12/1/2008)...st policy , , ROCHESTER, Minn., Dec. 1 /PR...ic finds the use of the drug therapy etanercept in...e inflammation of the liver caused by excessive co... published in the December issue of Gastroenterol... VIDEO ALERT: Additional audio and video resource...
(Date:12/1/2008)...rstCall/ -- Vical Incorporated (Nasdaq: VICL ) a...tone payment from Merck & Co., Inc. based on M...ial of an investigational plasmid DNA (pDNA) cance...,s DNA gene delivery technology and encodes human ... the subject of separate license agreement. , ...
(Date:11/27/2008)...acute lymphoblastic leukemia relapse cases arise f...s , , MEMPHIS, Tenn., Nov. 27 /PRNewswire-U...search Hospital have identified distinctive geneti...te lymphoblastic leukemia (ALL) that cause relapse...ents for ALL relapse in children and, ultimately, ...
(Date:11/25/2008)...wire-USNewswire/ -- Kleinert Kutz and University ....S. hand transplant on Messina, New York resident,...tal Hand Care Center on Monday, November 24. The ...pleted shortly after 9 p.m. in a record nine hours...bin/prnh/20081125/DC48555-a ) , (Photo: http:...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 1Oracle Healthcare Acquisition Corp Announces Stockholder Approval of Proposed Dissolution and Plan of Liquidation 18720 2Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday May 14 2008 5202 1FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 1FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 2FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation 5200 3ImaRx Schedules Release of First Quarter 2008 Financial Results 5198 1
...007 – Intercell AG (VSE,“ICLL”)...& Co., Inc. on the results of a Phase I study ...rs comparing safety and,immunogenicity of differen...he Staphylococcus aureus vaccine is based on a con...uo;s Antigen Identification,Program (AIP®) and...
...2007 /PRNewswire-FirstCall/ -- A total,of 20 oral ...Schering-Plough,s hepatitis products, including PE... (ribavirin, USP) combination,therapy for chronic ...previr (SCH 503034), the company,s investigational... clinical development, will,be presented by leadin...
Other Medicine Technology:Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 2Staphylococcus aureus vaccine development on track ? safe and,immunogenic in Phase I clinicaltrials 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 2Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 3Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 4Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 5Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 6Schering-Plough Announces Hepatitis C Data Presentations at,Digestive Disease Week (DDW) 2007 Annual Meeting 7
... integrated technology and service--mobile,outpati...heartbeat, ECG monitoring, analysis and response, ...y focused on helping physicians diagnose and treat...in diagnosing and treating arrhythmia. Delays can ...
...rmance temperature controlled shaker which accommo...eed and incubation time are fully programmable via...ed on the LCD in real time. Microprocessor-control... provide uniform incubation with less than 0.6 C v...
The iEMS Incubator/Shaker HT is designed for extended temperatures. Thus, the iEMS Incubator/Shaker HT is ideal for applications such as DNA hybridization and primer extension assays. iEMS Incubator/
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -
Medicine Products: